Match Document Document Title
US20140171357 VANCOMYCIN DERIVATIVES  
The invention features vancomycin class compounds modified to be suitable for oral delivery or to possess increased antimicrobial potency, formulations for the oral administration of vancomycin...
US20120263667 COMPOSITION AND METHOD FOR MODULATING AND MAINTAINING VAGINAL BACTERIAL FLORA AND VAGINAL ACIDITY  
The present invention relates to the use of benzoic acid and/or its sodium salt in combination with saccharide(s) as active components in the manufacture of a vaginal composition for modulating...
US20120245079 Treatment of Diseases Caused by Bacterial Exotoxins  
Provided are high affinity T cell receptor variable regions that are useful for treating diseases caused by superantigens including atopic dermatitis, pneumonia and delayed wound healing. The...
US20140274880 MOSQUITOCIDAL XENORHABDUS, LIPOPEPTIDE AND METHODS  
Provided is a bacterial strain which produces a family of mosquitocidal toxins, Xenorhabdus MT, on deposit with the American Type Culture Collection, PTA-6826, insecticidal compositions comprising...
US20150216806 LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS  
In alternative embodiments, the invention provides compositions, e.g., formulations or preparations, used for treating, ameliorating or preventing constipation and other disorders with related...
US20100061994 MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF  
The present invention relates to medical uses of 39-desmethoxyrapamycin analogues.
US20110110939 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF SYSTEMIC ANTHRAX INFECTION  
The present invention features methods and kits that utilize Ang-2 antagonists for the treatment, inhibition, and prevention of a systemic anthrax infection. The invention described herein also...
US20120122767 LACTOFERRIN-BASED BIOMATERIALS FOR TISSUE REGENERATION AND DRUG DELIVERY  
The invention provides biomatrix compositions comprising cross-linked lactoferrin, either alone or in combination with other organic or inorganic components. Also provided are methods of making...
US20120331576 Pathogen Restriction Factors  
The use of interferon induced transmembrane protein 1, 2, or 3 (IFITM1, 2, or 3) as a viral restriction factor, and methods of using the same to produce virus, transgenic animals expressing...
US20140031275 METHODS OF ERADICATING BACTERIAL CELL POPULATIONS  
Disclosed herein are methods and compositions for the eradication of bacterial infections. In particular, methods and compositions are disclosed for the eradication of persister and slow growing...
US20070142392 Uses of rifamycins  
The invention features methods, compositions, and kits for treating prosthetic joint infections, foreign body infections, infectious arthritis, and osteomyelitis
US20150017099 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES  
The invention provides methods and compositions for the diagnosis, prognosis and treatment of respiratory tract diseases. Specifically, the invention provides diagnosis, prognosis and treatment of...
US20120184482 Novel Ubiquitin-Isopeptide Probes  
The invention relates to a ubiquitin-isopeptide probe (hereinafter also referred to as UIPP), a method for its preparation, and its use. The invention also provides a method for isolating a...
US20130171252 Formulation Comprising a Type B Lantibiotic  
Described is a pharmaceutical formulation of a capsule for oral delivery of a type B lantibiotic to the stomach comprising a hard gelatine, HPMC or starch capsule, and a type B lantibiotic of...
US20150148286 POTENTIATION OF ANTIBIOTIC TREATMENT WITH A PROTEIN-LIPID COMPLEX  
Provided are compositions and methods for potentiating the effect of antibiotics. The compositions comprise a non-covalent complex of alpha-lactalbumin and fatty acid. The fatty acids are cis,...
US20120128701 COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS  
Methods of breaking down a biofilm or inhibiting, preventing or treating a microbial infection that produces a biofilm are disclosed, which involves administration of a polypeptide that has one or...
US20140287988 MACROGOL 15 HYDROXYSTEARATE FORMULATIONS  
Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
US20110294725 Use of predissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol  
A method of controlling microorganisms such as lactobacilli metabolism in mash in an ethanol production facility includes adding to the mash an effective amount to control such microorganisms of...
US20140140960 Plant disease resistance-related gene from soil metagenome and uses thereof  
The present invention relates to a recombinant vector containing a plant disease resistance-related 1B8-4-D7 gene from the soil metagenome, a host cell transformed with the recombinant vector, a...
US20130059773 COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND NEUTROPENIA  
The present invention concerns compounds modulating apoptosis of neutrophil cells. In particular, the invention concerns compounds inhibiting an interaction between Proliferating Cell Nuclear...
US20110053836 USE OF DEFENSINS AGAINST TUBERCULOSIS  
The present invention relates to a method for killing or inhibiting cells of Mycobacterium, in particular M. tuberculosis, with certain defensins.
US20130007924 INSECTCIDAL PROTEIN COMBINATIONS COMPRISING Cry1AB AND CRY2AA FOR CONTROLLING EUROPEAN CORN BORER, AND METHODS FOR INSECT RESISTANCE MANAGEMENT  
The subject invention relates in part to stacking a Cry IAb protein and a Cry2Aa protein to make plants (particularly corn or maize) more durable and less prone to allowing insects to develop that...
US20110038921 METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD  
The present invention provides methods and compositions for sequentially and separately reducing infection and/or inflammation and regenerating tissue at a lesion site, by contacting the lesion...
US20140141044 Cord Colitis Syndrome Pathogen  
The present invention provides a novel cord colitis syndrome pathogen as well as a method for the discovery of novel viral, prokaryotic or eukaryotic genomes or genomic fragments using a...
US20140371135 HIGH PURITY LIPOPEPTIDES  
The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential...
US20110207658 High Purity Lipopeptides  
The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential...
US20130150285 THERAPEUTIC AND COSMETIC USES AND APPLICATIONS OF CALRETICULIN  
Therapeutic and cosmetic uses and applications of calreticulin are provided. In particular, the invention relates to therapeutic and cosmetic uses and applications of calreticulin to a patient in...
US20150118208 ENHANCED AFFINITY T CELL RECEPTORS AND METHODS FOR MAKING THE SAME  
The present disclosure provides methods for generating enhanced affinity T cell receptors by agonist selection of hematopoietic progenitor cells expressing an antigen specific TCRα cultured with...
US20100104516 USE OF FLAGELLIN TO PREVENT AND TREAT GRAM NEGATIVE BACTERIAL INFECTION  
The disclosure describes use of flagellin polypeptides to induce tolerance to gram negative bacteria, such as Pseudomonas aeruginosa, in order to alleviate the effects of the inflammatory response...
US20130224131 4-AMIDINO BENZYLAMINES FOR COSMETIC AND/OR DERMATOLOGICAL USE  
This invention relates to the use of 4-amidino benzylamine derivatives as cosmetic ingredients and to cosmetic compositions, as well as to non-therapeutic methods for the cosmetic treatment of the...
US20110091450 METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION  
In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a living subject. In one embodiment, the invention provides methods of treating...
US20110160125 METHOD AND CULTURE MEDIUM FOR ENHANCED DETECTION OF MYCOBACTERIUM  
The present invention relates to an improved culture medium and method for the enhanced growth and detection of Mycobacterium growth. The invention further relates to an improved mycobacterial...
US20120015869 ANTIMICROBIAL AQUEOUS SOLUTION AND ITS PREPARATION METHOD  
The antimicrobial aqueous solution of the present invention comprises an original undiluted aqueous solution containing: 25 μg/ml to 50 μg/ml of an amphipathic preservative comprising a...
US20060171899 Water-stabilized aerosol formulation system and method of making  
The invention relates to an aerosol formulation system comprising a primary package system and an aerosol formulation therein wherein the aerosol formulation comprises insulin, a propellant and an...
US20060269484 Medicament formulations  
Disclosed are medicinal compositions, and devices, methods and systems which use same, comprising a propellant and at lease one medicinally active compound, said propellant comprising at least one...
US20140093477 MODULATING BACTERIAL MAM POLYPEPTIDES IN PATHOGENIC DISEASE  
The disclosure relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a multivalent adhesion...
US20150004165 SECRETED PROTEINS  
The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and...
US20140056906 SECRETED PROTEINS  
The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and...
US20140030218 Treatment And Screening  
A method of treating a patient having an autoimmune disease or a Th1 polarising infection or a condition associated with inflammation other than asthma or allergy, the method comprising...
US20140309159 COMPOSITIONS AND METHODS FOR TARGETING NUCLEAR IMPORT SHUTTLES AND TREATING INFLAMMATORY DISORDERS  
The present invention relates to compositions and methods for treating autoimmune, microbial, metabolic, neoplastic, and posttraumatic diseases mediated by inflammation in a subject. Compositions...
US20120009639 CONTROLLING MICROBIAL CONTAMINATION IN ALCOHOLIC FERMENTATION PROCESS  
The control of the microbial contamination during the sugar fermentation in the processes for obtaining alcohol is a very important action to increase the productivity of the alcoholic...
US20110229435 EXPRESSION AND PURIFICATION OF HIP/PAP AND USES THEREFOR  
The present invention relates to methods of compositions comprising RegIII and HIP/PAP proteins, including the use of such proteins as diagnostic and therapeutic targets.
US20120058936 COMPOSITIONS AND METHODS FOR ELIMINATION OF GRAM NEGATIVE BACTERIA  
Oral drug delivery formulations which specifically administer antibacterial agents to the ileum, caecum, and/or the colon, without significant administration elsewhere in the gastrointestinal...
US20120289456 ANTIMICROBIAL PROTEIN COMPOSITIONS AND USES THEREOF  
Several bacterial species were isolated from marine segment obtained from seabed sediment at depths exceeding 1700 feet. At least four of the bacteria produced a compound that showed antibacterial...
US20120283171 MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES  
Modified bovine somatotropin polypeptides and uses thereof are provided.
US20140206601 Methods and Pharmaceutical Compositions for the Treatment of Respiratory Tract Infections  
The present invention relates to methods and pharmaceutical compositions for the treatment of respiratory tract infections. More particularly, the present invention relates to a TLR5 agonist for...
US20130150286 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS  
The present invention relates to methods and pharmaceutical compositions for the treatment of respiratory tract infections. More particularly, the present invention relates to a TLR5 agonist for...
US20140082769 MOLECULES AND METHODS FOR INHIBITION AND DETECTION OF PROTEINS  
The present application belongs to the field of functional peptides and more particularly to the field of controlled protein aggregation. The invention discloses molecules of a peptide structure...
US20130059772 Use of Repeat Sequence Protein Polymers in Personal Care Compositions  
The present invention provides personal care compositions, and more particularly, personal care compositions comprising a bioactively effective amount of a repeat sequence protein polymer. In some...
US20140179593 METHODS AND COMPOSITIONS FOR INHIBITING NEDDYLATION OF PROTEINS  
Provided herein is a novel binding pocket within NEDD8 co-E3 proteins that binds NEDD8 E2 enzymes. Particularly at its M-Terminus. Methods are provided for screening for compounds that bind to the...